Supporting information for 'Inkjet printing of a thermolabile model drug onto FDM-printed substrates: formulation and evaluation'.
Georgios K. Eleftheriadis (Creator)
Christos S. Katsiotis (Creator)
Dimitrios A. Andreadis (Creator)
Dimitrios Tzetzis (Creator)
Christos Ritzoulis (Creator)
Nikolaos Bouropoulos (Creator)
Dimitra Kanellopoulou (Creator)
Eleftherios G. Andriotis (Creator)
John Tsibouklis (Creator)
Dimitrios G. Fatouros (Creator)
Dataset
Description
This copy of the Supplementary Material is subject to the same embargo as the post-print and will be available here from 01/07/21.
If your organisation has a subscription for the journal publisher (sometimes termed ‘authorised user’ or similar), the supplementary files are available online at https://doi.org/10.1080/03639045.2020.1788062
Eleftheriadis, G. K., Katsiotis, C. S., Andreadis, D. A., Tzetzis, D., Ritzoulis, C., Bouropoulos, N., Kanellopoulou, D., Andriotis, E. G., Tsibouklis, J. & Fatouros, D. G., 2 Aug 2020, In: Drug Development and Industrial Pharmacy.46, 8, p. 1253-126412 p.
Research output: Contribution to journal › Article › peer-review
Open Access
File
332Downloads
(Pure)
Cite this
DataSetCite
Eleftheriadis, G. K. (Creator), Katsiotis, C. S. (Creator), Andreadis, D. A. (Creator), Tzetzis, D. (Creator), Ritzoulis, C. (Creator), Bouropoulos, N. (Creator), Kanellopoulou, D. (Creator), Andriotis, E. G. (Creator), Tsibouklis, J. (Creator), Fatouros, D. G. (Creator) (4 Aug 2020). Supporting information for 'Inkjet printing of a thermolabile model drug onto FDM-printed substrates: formulation and evaluation'. Taylor & Francis. Supplementary_Information_Eleftheriadis_et_al_2020(.docx). 10.1080/03639045.2020.1788062